Navigation Links
Genesis Biosystems Unveils Innovative Skin Treatment at Esthétique SPA International Trade Show
Date:2/12/2013

how to use the system and educate their clients.

About Esthétique Spa International
Esthétique Spa International (ESI) offers the best education at the most affordable price in the spa and wellness industry.

Spa professionals gather at ESI events all over North America for practical business solutions, trend information and the latest offerings and insights from leading industry suppliers. For more than 20 years, ESI has been organized by tradeshow veterans Bernard Renaud and Robert Lamarche.

ESI attracts qualified visitors from North America and abroad. Personal attention, quality education and a carefully-chosen show floor of quality exhibitors are the hallmarks of all their shows. Comprehensive educational programs featuring renowned industry-leaders and curated show floor attract spa owners, managers, estheticians, massage therapists and medical professionals looking to expand their spa and esthetic services.

ESI events are focused exclusively on owners, directors and professionals in the aesthetic, spa and wellness industries. Only companies pertinent to the industry are invited to exhibit at ESI shows. For more information about the show visit http://spashowusa.com/.

About Genesis Biosystems
Genesis Biosystems Inc., a certified ISO 13485 manufacturer, produces quality aesthetic and biomedical products, including Derma Genesis® Microdermabrasion Systems for medical grade microdermabrasion treatments, DermaFrac™ Dermal Micro-Channeling infusion systems, LipiVage® Fat Transfer Systems and the AccelaFuze™ Combination Therapy System. Visit genesisbiosystems.com or call (888) 577-7335 for more information.

Read the full story at http://www.prweb.com/releases/2013/2/prweb1041919
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. ThermoGenesis Announces Approval of AXP® by India Ministry of Health
2. Scott Brooks Joins Regenesis Biomedical as Chief Operating Officer
3. ValGenesis Suite 2.5 Certified by SAP as Powered by SAP NetWeaver®
4. Genesis Biopharma Announces Proposed Public Offering of Common Stock and Warrants
5. Genesis Biopharma Issues Letter To Shareholders
6. Genesis Biopharma Mentioned Favorably in BioMedReports Article
7. Organogenesis Announces Annual College Scholarship Award Winner
8. Ahram Biosystems Announces Launch of the New Economy Model F1-12 of Its Palm PCR Series
9. Aushon BioSystems Appoints Martin Verhoef Chief Executive Officer
10. AyoxxA Biosystems Closes Series A Financing Round
11. Aushon BioSystems and AH diagnostics Sign Distribution Deal for Scandinavia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... 2013 Vestiage, Inc. (stock symbol ... on science-based research and development, sales and marketing ... nutraceuticals, announced today that it is awarding exclusive ... sale of Reluma Skin Illuminating Facial Care. Qualified ... by sending an email to info(at)vestiageinc(dot)com and putting ...
(Date:5/23/2013)... , May 23, 2013  BioScrip, Inc. (NASDAQ: ... present at the Jefferies 2013 Global Healthcare Conference to ... New York. Richard Smith ... Hai Tran , Chief Financial Officer, will present ... Daylight Time.   About BioScrip BioScrip, ...
(Date:5/23/2013)... 23, 2013  Rahal Letterman Lanigan Racing (RLL) and ... stem cell banking and therapeutics, announced today that StemCyte ... Acorn Stairlifts Indy car driven by James ... the IZOD IndyCar 2013 season.   StemCyte, ... support awareness of umbilical cord blood banking and its ...
(Date:5/23/2013)... Calif. , May 23, 2013 Virobay, ... treatment for pain has reached an important milestone, as ... of VBY-036 - a selective cathepsin S inhibitor.   ... is a double-blind, randomized, placebo-controlled study designed to evaluate ... of VBY-036 in healthy adults. "The initiation ...
Breaking Biology Technology:Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 3Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 4Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 5StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 2StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 3Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3
... , , , BRISBANE, ... results from operations for the second quarter and six months ended June 30, ... of 2009 of $36.7 million, or $0.81 per share, compared with a net ... 2008. , , Dan Welch, Chairman, Chief Executive ...
... ... Improved Website. The New Site Provides Users With A Comprehensive Overview Of Pace Analytical ... Also Offers An Expanded Service Description For Each Of Its Three Major Business Divisions: ... ...
... , REDWOOD CITY, Calif., Aug. ... antibody therapeutics that target cancer stem cells, today announced the ... potent anti-cancer activity in colon and breast cancer models for ... of targeting cancer stem cells to treat solid tumors. ...
Cached Biology Technology:InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 2InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 3InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 4InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 5InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 6InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 7InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 8InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 9InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 10InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 11InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 12InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 14InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 15One of the Nation's Leading Analytical Testing Laboratories is Now Easier to Access -- Pace Analytical Launches New Web Site to Showcase Its Three Business Divisions 2Data Published in Cell Stem Cell Demonstrates Potent Anti-Cancer Activity for OncoMed Pharmaceuticals' Lead Antibody 2Data Published in Cell Stem Cell Demonstrates Potent Anti-Cancer Activity for OncoMed Pharmaceuticals' Lead Antibody 3Data Published in Cell Stem Cell Demonstrates Potent Anti-Cancer Activity for OncoMed Pharmaceuticals' Lead Antibody 4
(Date:5/22/2013)... physicists have developed a novel technique that can detect ... process that is one of the most important, though ... in a paper in Nature , post-doctoral researcher ... Melanie Schnell of the Center for Free-Electron Laser Science ... on finely-tuned microwave fields to identify molecular variants apart, ...
(Date:5/22/2013)... environmental and human health effects from disposal of ... led scientists to recommend stronger government policies to ... battery materials. That,s the conclusion of a new ... & Technology . , Oladele A. Ogunseitan and ... mainstays for powering everything from smart phones to ...
(Date:5/22/2013)... Early screening for prostate cancer could become as easy ... thanks to UC Irvine research published today in the ... After more than a decade of work, UC Irvine ... usable markers for prostate cancer in urine, meaning that ... accuracy and at dramatically lower cost. The same technology ...
Breaking Biology News(10 mins):Detecting mirror molecules 2Detecting mirror molecules 3UCI chemists devise inexpensive, accurate way to detect prostate cancer 2UCI chemists devise inexpensive, accurate way to detect prostate cancer 3
... Extremely premature infants who screen positive for autism spectrum disorder ... autism. Rather, they may fail screening tests due to an ... presented Sunday, May 1, at the Pediatric Academic Societies (PAS) ... 110 U.S. children has ASD, a group of complex developmental ...
... born to obese mothers are at risk for iron ... a study to be presented Saturday, April 30, at ... In nonpregnant adults, obesity-related inflammation hinders the transport ... iron deficiency anemia. When a woman is pregnant, iron ...
... applauds the US Court of Appeals for the District of ... against the use of public funds for embryonic stem cell ... cell research and the nation,s scientific community. Most importantly, ... suffering from incurable diseases," says Susan L. Solomon, CEO of ...
Cached Biology News:Screening very preterm infants for autism at 18 months often inaccurate 2